BCM
FPRX

BCK Capital Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

BCK Capital Management’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-26,000
Closed -$979K – 162
2021
Q1 		$979K Buy
+26,000
New +$648K 0.54% 46

BCK Capital Management's FPRX Position: Q2 2021 in Review

BCK Capital Management sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 26,000 shares — an estimated $979K sold.

BCK Capital Management first reported a position in FPRX in Q1 2021 and held it in 1 quarter. The position peaked at $979K in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

  • BCK Capital Management reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
  • BCK Capital Management sold 26,000 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $979K.
  • BCK Capital Management first reported a position in Five Prime Therapeutics, Inc. in Q1 2021 and held it in 1 quarter.
  • BCK Capital Management's Five Prime Therapeutics, Inc. position peaked at $979K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on BCK Capital Management's 13F filing for Q2 2021, filed 20 Jul 2021.